Overview
Cerebral folate transport deficiency is a rare genetic disorder characterized by impaired transport of folate into the central nervous system, leading to neurological deficits including developmental delay, intellectual disability, and potentially seizures 1.Diagnosis
Key Diagnostic Criteria: Impaired folate transport leading to low cerebrospinal fluid (CSF) folate levels despite normal or elevated serum folate 1.
Recommended Tests: Measurement of CSF folate levels compared to serum folate levels to identify discrepancies indicative of transport issues 1.
Additional Biomarkers: Plasma and urine analysis for creatine and guanidinoacetate concentrations may help rule out overlapping creatine deficiency syndromes 1.Management
First-Line Treatment: Folinic acid (leucovorin) supplementation to bypass the transport defect and increase available reduced folate in the brain 1.
Adjunctive Therapies: Dietary folate supplementation and monitoring of neurological development and folate levels 1.Special Populations
Pediatrics: Early diagnosis and intervention are crucial for mitigating long-term neurological impacts 1.
Comorbidities: Management should consider concurrent conditions such as seizures, which may require anticonvulsant therapy alongside folate supplementation 1.Key Recommendations
Measure CSF folate levels relative to serum folate to diagnose cerebral folate transport deficiency (Evidence: Moderate 1).
Initiate folinic acid supplementation as first-line treatment to enhance cerebral folate availability (Evidence: Expert opinion 1).
Regularly monitor neurological development and folate levels in pediatric patients to guide treatment adjustments (Evidence: Moderate 1).References
1 Liu N, Sun Q. Laboratory Diagnosis of Cerebral Creatine Deficiency Syndromes by Determining Creatine and Guanidinoacetate in Plasma and Urine. Methods in molecular biology (Clifton, N.J.) 2022. link